Add GLP-1 Weight Loss to Your Denver MedSpa

What is a medspa GLP-1 program in Denver, CO?

A medspa GLP-1 program is a prescription weight loss service that a medical spa adds to its treatment menu, typically featuring compounded semaglutide or tirzepatide prescribed through telehealth. For medspas in Denver, CO, the program runs under your existing brand: clients complete an online intake, meet with a provider licensed in Colorado by video, and receive medication from an FDA-registered 503A or 503B pharmacy if it is clinically appropriate. Telehealth Grow supplies the provider network, pharmacy connections, consent templates, EMR and subscription billing, so your team does not need to hire a medical director solely for weight loss. The result is a recurring monthly revenue line that pairs naturally with body contouring, skin tightening and wellness treatments you already offer.

Why Denver is a strong market for a medspa GLP-1 program

With an estimated 740,613 residents (U.S. Census Bureau, 2025), Denver is the largest city in Colorado. It anchors the Denver–Aurora–Centennial, CO metropolitan area, a market of about 3,092,037 people.

Denver has grown 3.5% since 2020 — about 25,091 new residents — and that steady growth keeps widening the pool of adults looking for convenient weight loss options.

With about 4,674 residents per square mile, Denver blends dense neighborhoods with suburban commuting, a good fit for a hybrid model that pairs a local brand presence with virtual visits.

Denver accounts for about 24% of its metro population, and its +3.5% change since 2020 is roughly in line with Colorado as a whole (+4.1%). That makes it one of several demand centers in the region, so a telehealth brand that serves the whole metro captures far more patients than a single storefront.

Your patient base can extend well beyond Denver. Within driving distance are Aurora, CO (9 miles, 410K residents), Thornton, CO (12 miles, 148K residents), Lakewood, CO (13 miles, 157K residents) and Fort Collins, CO (55 miles, 172K residents), and telehealth lets one brand serve every one of them.

In Colorado, 22.6% of adults were living with obesity in 2020 CDC Behavioral Risk Factor Surveillance System (BRFSS) data — below the median across U.S. states of 31.3%. Applied to Denver’s adult population, that suggests roughly 130,600 adults who could be candidates for a GLP-1 conversation with a licensed provider.

The West has some of the lowest obesity prevalence in CDC data, so brands here win by pairing GLP-1 care with fitness, nutrition and longevity goals rather than selling weight loss alone.

For medspas and aesthetic practices, Denver offers the scale and demand to support a medspa GLP-1 program built on monthly subscriptions rather than one-off sales.

Colorado compliance snapshot for Denver

A medspa GLP-1 program serving Denver follows Colorado law. Three points matter most:

• Prescriber licensure: every patient located in Denver must be treated by a clinician licensed in Colorado.
• Nurse practitioner rules: Colorado is a full practice state in AANP’s classification, which shapes how physician oversight is structured.
• Ownership: the MSO-PC model keeps the business you own separate from the licensed clinical practice.

Read the full Colorado medspa GLP-1 program guide for telehealth prescribing, compounding and advertising rules. Our compliance team verifies current requirements for your business during onboarding; this is general information, not legal advice.

Revenue potential in Denver

Here is an illustrative projection. If a medspa GLP-1 program in Denver reached just 0.25% of the adults estimated to be living with obesity, and each active patient generated about $120 in monthly profit (the benchmark used in our revenue calculator), the numbers would look like this:

Illustration only, not a guarantee. Actual revenue depends on medication costs, dosages, pricing, telehealth visit fees, marketing spend and patient retention.